TD Securities analyst Derek Lessard downgrades Jamieson Wellness (TSX:JWEL) from Buy to Action List Buy and announces C$50 price target.
PolyPid Announces $16.2M Private Placement Of 3,371,312 Shares At $4.81/Share
The PIPE syndicate is comprised of new and existing investors, including participation from new U.S. life sciences-focused investors, DAFNA Capital Management and Rosalind Advisors. Under the securities purchase